Dominique Corneillo

With 30 years in the pharmaceutical industry, Dominique brings an extensive experience of biotech’s setting up, management and launch of biologicals and orphan drugs in rare or severe diseases.
From 2010 to 2015, Dominique created the French affiliate of Human Genome Sciences (HGS) and served as General Manager of HGS and InterMune successively, with direct responsibility for Market Access, Medical, Sales and Marketing. Between 2006 and 2010 Dominique built the Immunology Franchise of UCB for the launch of an anti-TNF in severe diseases.
Previously she spent 16 years with Bristol Myers Squibb, AstraZeneca and Lederle, in positions with increasing responsibility in operational and strategic marketing, locally and at European level, mainly in oncology and severe infectious diseases. She started her career in the medical devices.
Graduate of the University of San Francisco, Dominique holds an MBA from Institut Supérieur de Gestion (French Business School – Paris) and is certified as Board Member – Company Governance from Ecole de Management de Lyon.